Literature DB >> 29333576

Bone radionuclide therapy and increased survival with radium-223 is the way to go for nuclear medicine: the offer that oncologists cannot refuse.

Roberto C Delgado Bolton1, Francesco Giammarile2.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29333576     DOI： 10.1007/s00259-017-3913-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  10 in total

1.  Dosimetry in clinical radionuclide therapy: the devil is in the detail.

Authors:  Francesco Giammarile; Kristoff Muylle; Roberto Delgado Bolton; Jolanta Kunikowska; Uwe Haberkorn; Wim Oyen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-10       Impact factor: 9.236

2.  EANM guideline for radionuclide therapy with radium-223 of metastatic castration-resistant prostate cancer.

Authors:  Thorsten D Poeppel; Daria Handkiewicz-Junak; Michael Andreeff; Alexander Becherer; Andreas Bockisch; Eva Fricke; Lilli Geworski; Alexander Heinzel; Bernd J Krause; Thomas Krause; Markus Mitterhauser; Wilfried Sonnenschein; Lisa Bodei; Roberto C Delgado-Bolton; Michael Gabriel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-12       Impact factor: 9.236

Review 3.  18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis.

Authors:  Ana María García Vicente; Roberto C Delgado-Bolton; Mariano Amo-Salas; Jesús López-Fidalgo; Ana Paula Caresia Aróztegui; José Ramón García Garzón; Javier Orcajo Rincón; María José García Velloso; María de Arcocha Torres; Soledad Alvárez Ruíz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-27       Impact factor: 9.236

4.  Guideline for PET/CT imaging of neuroendocrine neoplasms with 68Ga-DOTA-conjugated somatostatin receptor targeting peptides and 18F-DOPA.

Authors:  Murat Fani Bozkurt; Irene Virgolini; Sona Balogova; Mohsen Beheshti; Domenico Rubello; Clemens Decristoforo; Valentina Ambrosini; Andreas Kjaer; Roberto Delgado-Bolton; Jolanta Kunikowska; Wim J G Oyen; Arturo Chiti; Francesco Giammarile; Anders Sundin; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-05-25       Impact factor: 9.236

5.  Alpha emitter radium-223 and survival in metastatic prostate cancer.

Authors:  C Parker; S Nilsson; D Heinrich; S I Helle; J M O'Sullivan; S D Fosså; A Chodacki; P Wiechno; J Logue; M Seke; A Widmark; D C Johannessen; P Hoskin; D Bottomley; N D James; A Solberg; I Syndikus; J Kliment; S Wedel; S Boehmer; M Dall'Oglio; L Franzén; R Coleman; N J Vogelzang; C G O'Bryan-Tear; K Staudacher; J Garcia-Vargas; M Shan; Ø S Bruland; O Sartor
Journal:  N Engl J Med       Date:  2013-07-18       Impact factor: 91.245

6.  Meta-analysis of the performance of 18F-FDG PET in primary tumor detection in unknown primary tumors.

Authors:  Roberto C Delgado-Bolton; Cristina Fernández-Pérez; Alfredo González-Maté; José L Carreras
Journal:  J Nucl Med       Date:  2003-08       Impact factor: 10.057

7.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Authors:  Ronald Boellaard; Roberto Delgado-Bolton; Wim J G Oyen; Francesco Giammarile; Klaus Tatsch; Wolfgang Eschner; Fred J Verzijlbergen; Sally F Barrington; Lucy C Pike; Wolfgang A Weber; Sigrid Stroobants; Dominique Delbeke; Kevin J Donohoe; Scott Holbrook; Michael M Graham; Giorgio Testanera; Otto S Hoekstra; Josee Zijlstra; Eric Visser; Corneline J Hoekstra; Jan Pruim; Antoon Willemsen; Bertjan Arends; Jörg Kotzerke; Andreas Bockisch; Thomas Beyer; Arturo Chiti; Bernd J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-02       Impact factor: 9.236

8.  Multicenter Comparison of Contrast-Enhanced FDG PET/CT and 64-Slice Multi-Detector-Row CT for Initial Staging and Response Evaluation at the End of Treatment in Patients With Lymphoma.

Authors:  Nieves Gómez León; Roberto C Delgado-Bolton; Lourdes Del Campo Del Val; Beatriz Cabezas; Reyes Arranz; Marta García; Jimena Cannata; Saturnino González Ortega; Mª Ángeles Pérez Sáez; Begoña López-Botet; Beatriz Rodríguez-Vigil; Marta Mateo; Patrick M Colletti; Domenico Rubello; José L Carreras
Journal:  Clin Nucl Med       Date:  2017-08       Impact factor: 7.794

9.  Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.

Authors:  Felisa Jiménez-Requena; Roberto C Delgado-Bolton; Cristina Fernández-Pérez; Sanjiv S Gambhir; Judy Schwimmer; José M Pérez-Vázquez; José L Carreras-Delgado
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-02       Impact factor: 9.236

10.  EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides.

Authors:  Daria Handkiewicz-Junak; Thorsten D Poeppel; Lisa Bodei; Cumali Aktolun; Samer Ezziddin; Francesco Giammarile; Roberto C Delgado-Bolton; Michael Gabriel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-16       Impact factor: 9.236
  10 in total
  2 in total

Review 1.  Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases.

Authors:  Chirayu M Patel; Thaddeus J Wadas; Yusuke Shiozawa
Journal:  Molecules       Date:  2021-04-09       Impact factor: 4.411

2.  Extended X-ray absorption fine structure spectroscopy measurements and ab initio molecular dynamics simulations reveal the hydration structure of the radium(II) ion.

Authors:  Akiko Yamaguchi; Kojiro Nagata; Keita Kobayashi; Kazuya Tanaka; Tohru Kobayashi; Hajime Tanida; Kojiro Shimojo; Tetsuhiro Sekiguchi; Yui Kaneta; Shohei Matsuda; Keiichi Yokoyama; Tsuyoshi Yaita; Takashi Yoshimura; Masahiko Okumura; Yoshio Takahashi
Journal:  iScience       Date:  2022-07-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.